Get started
Author

Claudia Sedlinsky

Observed names: C Sedlinsky, C. Sedlinsky, Claudia E. Sedlinsky, Sedlinsky Claudia, Sedlinsky, Claudia
ORCID: 0009-0006-1825-9397
Observed ORCID: 0009-0006-1825-9397
OpenAlex ID: A5061685726
Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture
2006 · Ana M. Cortizo, Claudia Sedlinsky, et al. · European Journal of Pharmacology · 242
Effect of metformin on bone marrow progenitor cell differentiation: In vivo and in vitro studies
2009 · M Silvina Molinuevo, Leon Schurman, et al. · Journal of Bone and Mineral Research · 239
PDF
Metformin Reverts Deleterious Effects of Advanced Glycation End-Products (AGEs) on Osteoblastic Cells
2008 · L. Schurman, A. McCarthy, et al. · Experimental and Clinical Endocrinology & Diabetes · 99
Insulin-deficient diabetes-induced bone microarchitecture alterations are associated with a decrease in the osteogenic potential of bone marrow progenitor cells: Preventive effects of metformin
2013 · María José Tolosa, Sara Rocío Chuguransky, et al. · Diabetes Research and Clinical Practice · 72
PDF
Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats
2011 · Claudia Sedlinsky, María Silvina Molinuevo, et al. · European Journal of Pharmacology · 68
Metformin revisited: Does this regulator of AMP-activated protein kinase secondarily affect bone metabolism and prevent diabetic osteopathy
2016 · Antonio Desmond McCarthy, Ana María Cortizo, et al. · World Journal of Diabetes · 59
PDF
Effects of fructose-induced metabolic syndrome on rat skeletal cells and tissue, and their responses to metformin treatment
2017 · Juan Ignacio Felice, León Schurman, et al. · Diabetes Research and Clinical Practice · 34
PDF
Saxagliptin affects long-bone microarchitecture and decreases the osteogenic potential of bone marrow stromal cells
2014 · María Laura Sbaraglini, María Silvina Molinuevo, et al. · European Journal of Pharmacology · 33
PDF
Advanced glycation end products and strontium ranelate promote osteogenic differentiation of vascular smooth muscle cells in vitro: Preventive role of vitamin D
2017 · María Silvina Molinuevo, Juan Manuel Fernández, et al. · Molecular and Cellular Endocrinology · 29
PDF
Strontium ranelate prevents the deleterious action of advanced glycation endproducts on osteoblastic cells via calcium channel activation
2013 · Juan Manuel Fernández, María Silvina Molinuevo, et al. · European Journal of Pharmacology · 24
[Argentine guidelines for the diagnosis, prevention and treatment of osteoporosis, 2015].
2017 · León Schurman, Ana M Galich, et al. · Actualizaciones en osteología · 11
PDF
Estrogenic status influences nitric oxide-regulated TNF-α release from human peripheral blood monocytes
2001 · L. Schurman, C. Sedlinsky, et al. · Experimental and Clinical Endocrinology & Diabetes · 9
Metformin reverts aortic calcifications and elastin loss induced by an experimental metabolic syndrome
2025 · Lucas Streckwall, Nancy Martini, et al. · Endocrine Connections · 7
PDF
Skeletal Effects of a Prolonged Oral Metformin Treatment in Adult Wistar Rats
2024 · Nahuel E. Wanionok, María S. Molinuevo, et al. · Experimental and Clinical Endocrinology & Diabetes · 6
Effects of advanced glycation end-products, diabetes and metformin on the osteoblastic transdifferentiation capacity of vascular smooth muscle cells: In vivo and in vitro studies
2023 · María Silvina Molinuevo, Ana María Cortizo, et al. · Journal of Diabetes and its Complications · 6
Incidence and predictive factors of postoperative hypocalcaemia according to type of thyroid surgery in older adults
2021 · María Paz Barbier, Evelin Mingote, et al. · Endocrine · 5
Tratamiento con metformina previene la adiposidad de la médula ósea femoral inducida por un síndrome metabólico experimental en ratas
2024 · Siro Lasalvia, Claudia Sedlinsky, et al. · Revista Peruana de Medicina Experimental y Salud Pública · 4
Editorial: Molecular and cellular mechanisms of bone remodeling
2026 · Sandeep Kumar, Antonio Desmond McCarthy, et al. · Frontiers in Endocrinology · 1
PDF
La diabetes altera el potencial osteogénico de células progenitoras de médula ósea. Efectos del tratamiento con metformina Diabetes Decreases the Osteogenic Potential of Bone Marrow Progenitor Cells. Effects of Treatment with Metformin
2012 · María José Tolosa, Sara Chuguransky, et al. · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · 1
PDF
Correction: Editorial: Molecular and cellular mechanisms of bone remodeling
2026 · Sandeep Kumar, Antonio Desmond McCarthy, et al. · Frontiers in Endocrinology
PDF
Osteoporosis en la mujer con diabetes
2026 · Sedlinsky, Claudia · Revista de la Sociedad Argentina de Diabetes
PDF
El tratamiento oral con metformina previene signos tempranos de arterioesclerosis aórtica inducida por AGE/RAGE en ratas con síndrome metabólico
2026 · Streckwall, Lucas, Martini, Nancy, et al. · Actualizaciones en osteología
PDF
Ritmos circadianos, sueño y salud ósea
2024 · Sedlinsky, Claudia · Actualizaciones en osteología
PDF
Osteoporosis
2023 · Claudia Sedlinsky · Revista de la Sociedad Argentina de Diabetes
PDF
Correction to: Incidence and predictive factors of postoperative hypocalcaemia according to type of thyroid surgery in older adults
2021 · María Paz Barbier, Evelin Mingote, et al. · Endocrine
PDF
Works count: 36
Citation count: 956
H-index: 11
I10-index: 11
Year
Topic
Type